|
| Exchange Disseminated Time | Panacea Biotec Ltd has informed BSE that the 27th Annual General Meeting (AGM) of the members of the Company will be held on September 24, 2011 at 11.00 A.M. at the Registered Office of the company at Ambalal-Chandigarh Highway, Lalru - 140501, Punjab to transact the following business:
1. To receive, consider and adopt the Audited Balance Sheet as at March 31, 2011 and the Profit & Loss Account for the year ended on that date and the reports of Directors and Auditors thereon.
2. To declare dividend on Equity Shares of the Company.
3. To appoint a director in place of Dr. A.N. Saksena, who retires by rotation, and being eligible, offers himself for re-appointment.
4. To appoint a director in place of Mr. Sumit Jain, who retires by rotation, and being eligible, offers himself for re-appointment.
5. To appoint a director in place of Mr. R.L. Narasimhan, who retires by rotation, and being eligible, offers himself for re-appointment.
6. To appoint M/s. S.R. Batliboi & Co., Chartered Accountants, the retiring auditors as Statutory Auditors of the Company to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting and to fix their remuneration.
7. Re-appointment of Mr. Soshil Kumar Jain as Whole-time Director designated as Chairman of the Company for a period of five years w.e.f. April 01, 2011 on remuneration, terms & conditions.
8. Re-appointment of Mr. Ravinder Jain as Managing Director of the Company for a period of five years w.e.f. April 01, 2011 on remuneration, terms & conditions.
9.Re-appointment of Dr. Rajesh Jain as Joint Managing Director of the Company for a period of five years w.e.f. April 01, 2011 on remuneration, terms & conditions.
10. Re-appointment of Mr. Sandeep Jain as Joint Managing Director of the Company for a period of five years w.e.f. April 01, 2011 on remuneration, terms & conditions.
11. To authorise the Board to sanction suitable increments and/or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Mr. Shagun Jain, as approved by the shareholders and the Central Government from time to time.
12. To authorise the Board to sanction suitable increments and/or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Ms. Radhika Jain, as approved by the shareholders and the Central Government from time to time.
13. To authorise the Board to sanction suitable increments and/or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Ms. Shilpy Jain, as approved by the shareholders from time to time.
14. To authorise the Board to sanction suitable increments and/or change of role/designation (including promotion in due course to a higher designation), which the Board may, in its own discretion, decide from time to time within and subject to the remuneration and other terms of appointment of Mr. Ankesh Jain, as approved by the shareholders from time to time. |
|
|